OptimizeRx (OPRX) announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPRX:
- OptimizeRx Stockholders Approve Key Governance Proposals
- OptimizeRx price target raised to $16 from $12.50 at Stifel
- OptimizeRx Earnings Call: Positive Growth and Strategic Shifts
- OptimizeRx price target raised to $18 from $13 at B. Riley
- OptimizeRx price target raised to $22 from $16 at Roth Capital